Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of HY-072808 ointment in adults with mild to moderate atopic dermatitis
ChiCTR2400094201Phase 2Completed
- Sponsor
- Peking University People's Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HY-072808 in atopic dermatitis (AD) (3 arms), sponsored by Peking University People's Hospital. Primary endpoint: Eczema Area and Severity Index. Started Dec 2024; status: completed.
02
Drugs
HY-072808
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2400094201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094201.